"The panel urges clinicians to consider the pretest probability of AD pathology for each patient when deciding whether or not to use a BBM test,” and not as a standalone diagnostic tool.
Neuroimaging detects reduced grey matter in multiple brain regions among breast cancer patients after chemotherapy, raising concern for long-term cognitive risks.
Compared to those with longer telomeres, individuals with the shortest telomeres demonstrated an 8% higher risk of stroke, a 19% higher risk of dementia, and a 14% higher risk of late-life depression.
High fluctuations in total cholesterol were associated with a 60% increase in dementia risk, while stable levels showed significantly lower cognitive decline over six years in a study of 9,846 elderly adults.
In the “The Culture Cure: Heal Your Practice With Team Retention, Patient Trust & Profitability” session at the 2025 ASCRS meeting, Hayley G. Boling, MBA, COE, CEO of Boling Vision Center, INSIGHT Surgery Center, INFOCUS Optical Lab, and HGB Consulting, provided a look at how to identify a toxic culture in a practice.